{
  "docId": "019de070-ff46-75e9-a6a2-27d0e899d3b8",
  "docSlug": "714b2223d61a474cc0c3d011e3fc18ab",
  "documentTitle": "Centessa | IPO Presentation Deck | 33 slides",
  "authorId": "centessa",
  "authorName": "Centessa Pharmaceuticals",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investment_bank",
  "sourceTypeLabel": "Investment bank",
  "presentationDate": "2021-05-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7843866,
  "pageNumber": 13,
  "pageCount": 33,
  "prevPage": 12,
  "nextPage": 14,
  "slideType": "comparison_table",
  "function": "illustrate_case",
  "density": "dense",
  "nDataPoints": 2,
  "notes": "The slide uses a before-after-bridge framing to show drug safety.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de070-ff46-75e9-a6a2-27d0e899d3b8/13",
  "deckHref": "/decks/019de070-ff46-75e9-a6a2-27d0e899d3b8",
  "deckJsonHref": "/decks/019de070-ff46-75e9-a6a2-27d0e899d3b8.json",
  "deckAnchorHref": "/decks/019de070-ff46-75e9-a6a2-27d0e899d3b8#slide-13",
  "components": [
    {
      "bbox": {
        "h": 0.3,
        "w": 0.55,
        "x": 0.38,
        "y": 0.6
      },
      "kind": "chart",
      "text": "Lixivaptan dose vs ALT levels over time",
      "attrs": null,
      "subkind": "line",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "2a63584c-afed-4ab4-b70d-50b175d18907",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.3,
        "w": 0.55,
        "x": 0.38,
        "y": 0.18
      },
      "kind": "chart",
      "text": "Tolvaptan dose vs ALT levels over time",
      "attrs": null,
      "subkind": "line",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d0a9f9a3-00f6-4810-96eb-5201fb020afa",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.3,
        "x": 0.05,
        "y": 0.6
      },
      "kind": "paragraph",
      "text": "Subsequent experience with lixivaptan: Same patient enrolled in compassionate use study under Palladio's IND for treatment of ADPKD. Lixivaptan did not cause any signs of liver toxicity in this highly susceptible patient during 14 months of therapy",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "68a702ea-1844-4743-acb2-a1c8680c3af9",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.3,
        "x": 0.05,
        "y": 0.2
      },
      "kind": "paragraph",
      "text": "Initial experience with tolvaptan: Young patient with ADPKD developed drug-induced liver toxicity (DILI) on each of three unsuccessful attempts to initiate therapy with tolvaptan. Patient's response to tolvaptan shows classic signs of idiosyncratic DILI",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "dc48c6ad-f82b-48b4-a707-68a4280d3080",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.7,
        "x": 0.05,
        "y": 0.05
      },
      "kind": "title",
      "text": "Lixivaptan: No Liver Tox Observed in Single Patient Who Experienced Liver Tox On Tolvaptan",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "5736edae-4e54-4518-857b-b184389a8ac6",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "before-after-bridge",
      "slug": null,
      "matchId": "5bc64d46-73e3-4b34-9321-7d2b66c1bd3c",
      "evidence": "Compares negative outcome of Tolvaptan with positive outcome of Lixivaptan in the same patient.",
      "confidence": 0.9
    }
  ],
  "arcBeats": [
    {
      "to": 15,
      "from": 11,
      "beatId": "858c031e-6b1f-41e5-b1d3-a2219b0e9631",
      "arcName": "The Sequoia Pitch",
      "arcSlug": "sequoia-pitch",
      "beatName": "Market Size",
      "beatSlug": "sequoia-pitch-market-size",
      "evidence": "The deck provides data on the market potential of the company's treatments",
      "position": 2,
      "confidence": 0.8,
      "parentBeatName": "Evidence",
      "parentBeatSlug": "evidence"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}